DFN 11

Drug Profile

DFN 11

Alternative Names: DFN-11; sumatriptan succinate; ZEMBRACESymTouch

Latest Information Update: 08 Aug 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Promius Pharma
  • Class Antimigraines; Indoles; Small molecules; Sulfonamides; Tryptamines
  • Mechanism of Action Serotonin 1B receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Migraine

Most Recent Events

  • 26 Feb 2018 Dr. Reddy's Laboratories completes a phase III trial for Migraine in USA (SC) (NCT02569853)
  • 15 Nov 2017 Adverse events and efficacy data from a phase III trial in Migraine released by Promius Pharma
  • 19 Dec 2016 Dr. Reddy's Laboratories terminates a pilot phase II trial in Migraine (medication overuse headaches) in USA (Parenteral) (NCT02583425)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top